The first three patients to undergo the procedure did so without complication and were discharged as planned, Rabin Medical Center announced.

Researchers say a new drug-delivery implant could help patients with hard-to-treat bladder cancer avoid losing their bladders — and stay cancer-free for years.

Doctors at Rabin Medical Center successfully deploy homegrown CAR-T therapy for multiple myeloma.The post Israeli medical breakthrough: a new treatment for blood cancer appeared first on JNS.org.

UCLA researchers have developed a CAR-NKT cell therapy that has shown to be more effective than current immunotherapies at fighting ...

A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine ...

Roughly a quarter of all cancerous tumors are caused by mutations in the KRAS gene, which fosters cell growth. For more than ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...

Researchers advance mRNA cancer therapies as France tests new methods, while the FDA approves Bayer’s Hyrnuo for HER2-mutated ...

QIMR Berghofer researcher Lachlan Harris has been awarded the prestigious National Stem Cell Foundation of Australia’s 2025 Metcalf Prize.

Broadcasting legend Sandy Roberts is celebrating a major win in the fight against cancer, with the federal government ...

A stone's throw from Dublin's Merrion Square, where medical luminaries such as William Stokes and William Wilde plied their ...